Schmiedl Andreas, Vieten Gertrud, Mühlfeld Christian, Bernhard Wolfgang
Department of Anatomy, Hannover Medical School, Hannover, Germany.
Pediatr Pulmonol. 2007 Jun;42(6):548-62. doi: 10.1002/ppul.20623.
Pulmonary surfactant prevents alveolar collapse via reduction of surface tension. In contrast to human neonates, rats are born with saccular lungs. Therefore, rat lungs serve as a model for investigation of the surfactant system during postnatal alveolar formation. We hypothesized that this process is associated with characteristic structural and biochemical surfactant alterations. We aimed to discriminate changes related to alveolarization from those being either invariable or follow continuous patterns of postnatal changes. Secreted active (mainly tubular myelin (tm)) and inactive (unilamellar vesicles (ulv)) surfactant subtypes as well as intracellular surfactant (lamellar bodies (lb)) in type II pneumocytes (PNII) were quantified before (day (d) 1), during (d 7), at the end of alveolarization (d 14), and after completion of lung maturation (d 42) using electron microscopic methods supplemented by biochemical analyses (phospholipid quantification, immunoblotting for SP-A). Immunoelectron microscopy determined the localization of surfactant protein A (SP-A). (1) At d 1 secreted surfactant was increased relative to d 7-42 and then decreased significantly. (2) Air spaces of neonatal lungs comprised lower fractions of tm and increased ulv, which correlated with low SP-A concentrations in lung lavage fluid (LLF) and increased respiratory rates, respectively. (3) Alveolarization (d 7-14) was associated with decreasing PNII size although volume and sizes of Lb continuously increased. (4) The volume fractions of Lb correlated well with the pool sizes of phospholipids in lavaged lungs. Our study emphasizes differential patterns of developmental changes of the surfactant system relative to postnatal alveolarization.
肺表面活性物质通过降低表面张力来防止肺泡塌陷。与人类新生儿不同,大鼠出生时肺为囊状肺。因此,大鼠肺可作为研究出生后肺泡形成过程中表面活性物质系统的模型。我们假设这一过程与表面活性物质特征性的结构和生化改变有关。我们旨在区分与肺泡化相关的变化与那些不变或遵循出生后连续变化模式的变化。在出生前(第1天)、出生期间(第7天)、肺泡化结束时(第14天)和肺成熟完成后(第42天),使用电子显微镜方法并辅以生化分析(磷脂定量、SP-A免疫印迹)对II型肺细胞(PNII)中分泌的活性(主要是管状髓磷脂(tm))和非活性(单层囊泡(ulv))表面活性物质亚型以及细胞内表面活性物质(板层小体(lb))进行定量。免疫电子显微镜确定表面活性物质蛋白A(SP-A)的定位。(1)与第7 - 42天相比,第1天分泌的表面活性物质增加,然后显著下降。(2)新生肺的气腔中tm比例较低,ulv增加,这分别与肺灌洗液(LLF)中低浓度的SP-A和呼吸频率增加相关。(3)肺泡化(第7 - 14天)与PNII大小减小有关,尽管lb的体积和大小持续增加。(4)lb的体积分数与灌洗肺中磷脂的总量密切相关。我们的研究强调了表面活性物质系统相对于出生后肺泡化的发育变化的差异模式。